Key result
Tumour necrosis factor alpha acts as a key regulator of adipose tissue mass by inhibiting adipogenesis and lipogenesis while promoting lipolysis and apoptosis.
TNFalpha acts as a key regulator of adipose tissue mass, with implications for metabolic disorders like obesity and insulin resistance.
In addition to its established role in the immune system, tumour necrosis factor alpha (TNFalpha) exerts complex regulatory actions on adipose tissue. TNFalpha is produced in and secreted by the adipocyte and thus is in a position to exert a paracrine and/or autocrine role within adipose tissue. TNFalpha affects many aspects of adipocyte function, from adipocyte development to lipid metabolism. Bringing together all of these diverse actions, TNFalpha appears to play a general role in reducing adipose tissue mass. Dysregulation of TNFalpha production and/or action could be one facet in the development of cachexia and obesity, as well as associated metabolic disorders such as insulin resistance.
No takes yet. Share an insight, caveat, or question.
James P. Warne (2003) conducted a review in Adipose tissue mass regulation. Tumour necrosis factor alpha (TNF-alpha) was evaluated. Tumour necrosis factor alpha acts as a key regulator of adipose tissue mass by inhibiting adipogenesis and lipogenesis while promoting lipolysis and apoptosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: